@ARTICLE{
author={Livingstone E,...,Kandolf Lidija O,...,(broj koautora 25)},
year={2025},
title={Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial},
journal={ESMO OPEN},
volume={10},
number={5},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Livingstone E,...,Kandolf-Sekulovic Lidija O,...,Mijuskovic Zeljko P,...,(broj koautora 24)},
year={2023},
title={Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial},
journal={EUROPEAN JOURNAL OF CANCER},
volume={190},
number={},
pages={-},
document_type={Article},
}